Immediate Impact

35 standout
Sub-graph 1 of 16

Citing Papers

Oncolytic mineralized bacteria as potent locally administered immunotherapeutics
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
2 intermediate papers

Works of Karin Berghoff being referenced

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
2020

Author Peers

Author Last Decade Papers Cites
Karin Berghoff 117 128 112 28 263
Philippe Jamme 149 109 103 22 248
Luciano Latini 88 109 105 25 255
Shiaowen David Hsu 122 171 98 35 293
Kiruthikah Thillai 58 127 158 25 283
Kristen K. Ciombor 75 187 82 23 300
Antonino Cassata 51 214 45 21 282
Haruyuki ANZAI 86 101 152 20 323
Francesca Comito 108 127 76 25 320
Shenglan Huang 65 68 143 22 277
Chen‐Yang Huang 129 171 56 35 324

All Works

Loading papers...

Rankless by CCL
2026